All populations - Both genders

Calcium AI, AR, PRIs: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4101

UL: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2012.2814

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 280 mg/day NA NA NA ND

genders
Children 1-3 years Both NA 390 mg/day 450 mg/day NA ND
genders
Children 4-10 years Both NA 680 mg/day 800 mg/day NA ND
genders
Children 11-17 years Both NA 960 mg/day 1150 mg/ NA ND
genders day
Adults 18-24 years Both NA 860 mg/day 1000 mg/ NA 2500 mg/
genders day day
Adults ≥ 25 years Both NA 750 mg/day 950 mg/day NA 2500 mg/
genders day
Pregnant women 18-24 years Female NA 860 mg/day 1000 mg/ NA 2500 mg/
day day
Pregnant women ≥ 25 years Female NA 750 mg/day 950 mg/day NA 2500 mg/
day
Lactating women 18-24 years Female NA 860 mg/day 1000 mg/ NA 2500 mg/
day day
Lactating women ≥ 25 years Female NA 750 mg/day 950 mg/day NA 2500 mg/
day

Chloride AI: NOT AVAILABLE YET

Safe and adequate intake: https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2019.5779

Age Gender AI AR PRIs RI UL Safe and

adequate
intake

Infants 7-11 months Both 0.3 g/day NA NA NA NA NA

genders
Children 1-3 years Both NA NA NA NA NA 1.7 g/day
genders
Children 4-6 years Both NA NA NA NA NA 2 g/day
genders
Children 7-10 years Both NA NA NA NA NA 2.6 g/day
genders
Children 11-17 years Both NA NA NA NA NA 3.1 g/day
genders
Adults ≥ 18 years Both NA NA NA NA NA 3.1 g/day
genders
Pregnant women ≥ 18 years Both NA NA NA NA NA 3.1 g/day
genders
Lactating women ≥ 18 years Both NA NA NA NA NA 3.1 g/day
genders

Copper AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4253

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 0.4 mg/day NA NA NA ND

Copyright @2019 EFSA 1/6

 Age Gender AI AR PRIs RI UL

genders
Children 1-2 years Both 0.7 mg/day NA NA NA 1 mg/day
genders
Children 3 years Both 1 mg/day NA NA NA 1 mg/day
genders
Children 4-6 years Both 1 mg/day NA NA NA 2 mg/day
genders
Children 7-9 years Both 1 mg/day NA NA NA 3 mg/day
genders
Children 10 years Male 1.3 mg/day NA NA NA 3 mg/day
Children 10 years Female 1.1 mg/day NA NA NA 3 mg/day
Children 11-17 years Male 1.3 mg/day NA NA NA 4 mg/day
Children 11-17 years Female 1.1 mg/day NA NA NA 4 mg/day
Adults ≥ 18 years Male 1.6 mg/day NA NA NA 5 mg/day
Adults ≥ 18 years Female 1.3 mg/day NA NA NA 5 mg/day
Pregnant women ≥ 18 years Female 1.5 mg/day NA NA NA ND
Lactating women ≥ 18 years Female 1.5 mg/day NA NA NA ND

Fluoride AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3332

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 0.4 mg/day NA NA NA ND

genders
Children 1-3 years Both 0.6 mg/day NA NA NA 1.5 mg/day
genders
Children 4-6 years Male 1 mg/day NA NA NA 2.5 mg/day
Children 4-6 years Female 0.9 mg/day NA NA NA 2.5 mg/day
Children 7-8 years Male 1.5 mg/day NA NA NA 2.5 mg/day
Children 7-8 years Female 1.4 mg/day NA NA NA 2.5 mg/day
Children 9-10 years Male 1.5 mg/day NA NA NA 5 mg/day
Children 9-10 years Female 1.4 mg/day NA NA NA 5 mg/day
Children 11-14 years Male 2.2 mg/day NA NA NA 5 mg/day
Children 11-14 years Female 2.3 mg/day NA NA NA 5 mg/day
Children 15-17 years Male 3.2 mg/day NA NA NA 7 mg/day
Children 15-17 years Female 2.8 mg/day NA NA NA 7 mg/day
Adults ≥ 18 years Male 3.4 mg/day NA NA NA 7 mg/day
Adults ≥ 18 years Female 2.9 mg/day NA NA NA 7 mg/day
Pregnant women ≥ 18 years Female 2.9 mg/day NA NA NA 7 mg/day
Lactating women ≥ 18 years Female 2.9 mg/day NA NA NA 7 mg/day

Iodine AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2014.3660

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 70 μg/day NA NA NA ND

genders
Children 1-3 years Both 90 μg/day NA NA NA 200 μg/day
genders
Children 4-6 years Both 90 μg/day NA NA NA 250 μg/day
genders
Children 7-10 years Both 90 μg/day NA NA NA 300 μg/day
genders
Children 11-14 years Both 120 μg/day NA NA NA 450 μg/day

Copyright @2019 EFSA 2/6

 Age Gender AI AR PRIs RI UL

genders
Children 15-17 years Both 130 μg/day NA NA NA 500 μg/day
genders
Adults ≥ 18 years Both 150 μg/day NA NA NA 600 μg/day
genders
Pregnant women ≥ 18 years Female 200 μg/day NA NA NA 600 μg/day
Lactating women ≥ 18 years Female 200 μg/day NA NA NA 600 μg/day

Iron AR, PRIs: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4254

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both NA 8 mg/day 11 mg/day NA ND

genders
Children 1-6 years Both NA 5 mg/day 7 mg/day NA ND
genders
Children 7-11 years Both NA 8 mg/day 11 mg/day NA ND
genders
Children 12-17 years Male NA 8 mg/day 11 mg/day NA ND
Children 12-17 years Female NA 7 mg/day 13 mg/day NA ND
Premenopausal ≥ 18 years Female NA 7 mg/day 16 mg/day NA ND
women
Postmenopausal ≥ 40 years Female NA 6 mg/day 11 mg/day NA ND
women
Adults ≥ 18 years Male NA 6 mg/day 11 mg/day NA ND
Pregnant women ≥ 18 years Female NA 7 mg/day 16 mg/day NA ND
Lactating women ≥ 18 years Female NA 7 mg/day 16 mg/day NA ND

For premenopausal women (including lactating and pregnant women), the PRI covers the requirement of approximately 95 % of women.

Magnesium AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4186

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 80 mg/day NA NA NA ND

genders
Children 1-2 years Both 170 mg/day NA NA NA ND
genders
Children 3 years Both 230 mg/day NA NA NA ND
genders
Children 4-9 years Both 230 mg/day NA NA NA 250 mg/day
genders
Children 10-17 years Male 300 mg/day NA NA NA 250 mg/day
Children 10-17 years Female 250 mg/day NA NA NA 250 mg/day
Adults ≥ 18 years Male 350 mg/day NA NA NA 250 mg/day
Adults ≥ 18 years Female 300 mg/day NA NA NA 250 mg/day
Pregnant women ≥ 18 years Female 300 mg/day NA NA NA 250 mg/day
Lactating women ≥ 18 years Female 300 mg/day NA NA NA 250 mg/day

Manganese AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3419

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 0.02–0.5 NA NA NA ND

Copyright @2019 EFSA 3/6

 Age Gender AI AR PRIs RI UL

genders mg/day
Children 1-3 years Both 0.5 mg/day NA NA NA ND
genders
Children 4-6 years Both 1 mg/day NA NA NA ND
genders
Children 7-10 years Both 1.5 mg/day NA NA NA ND
genders
Children 11-14 years Both 2 mg/day NA NA NA ND
genders
Children 15-17 years Both 3 mg/day NA NA NA ND
genders
Adults ≥ 18 years Both 3 mg/day NA NA NA ND
genders
Pregnant women ≥ 18 years Female 3 mg/day NA NA NA ND
Lactating women ≥ 18 years Female 3 mg/day NA NA NA ND

For infants, in view of the wide range of manganese intakes that appear to be adequate, a range is set for the AI of this age group.

Molybdenum AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3333

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 10 μg/day NA NA NA ND

genders
Children 1-3 years Both 15 μg/day NA NA NA 0.1 mg/day
genders
Children 4-6 years Both 20 μg/day NA NA NA 0.2 mg/day
genders
Children 7-10 years Both 30 μg/day NA NA NA 0.25 mg/day
genders
Children 11-14 years Both 45 μg/day NA NA NA 0.4 mg/day
genders
Children 15-17 years Both 65 μg/day NA NA NA 0.5 mg/day
genders
Adults ≥ 18 years Both 65 μg/day NA NA NA 0.6 mg/day
genders
Pregnant women ≥ 18 years Female 65 μg/day NA NA NA 0.6 mg/day
Lactating women ≥ 18 years Female 65 μg/day NA NA NA 0.6 mg/day

Phosphorus AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4185

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 years Both 160 mg/day NA NA NA ND

genders
Children 1-3 years Both 250 mg/day NA NA NA ND
genders
Children 4-10 years Both 440 mg/day NA NA NA ND
genders
Children 11-17 years Both 640 mg/day NA NA NA ND
genders
Adults ≥ 18 years Both 550 mg/day NA NA NA ND
genders
Pregnant women ≥ 18 years Female 550 mg/day NA NA NA ND
Lactating women ≥ 18 years Female 550 mg/day NA NA NA ND

Copyright @2019 EFSA 4/6

 Potassium AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4592

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 750 mg/day NA NA NA ND

genders
Children 1-3 years Both 800 mg/day NA NA NA ND
genders
Children 4-6 years Both 1100 mg/ NA NA NA ND
genders day
Children 7-10 years Both 1800 mg/ NA NA NA ND
genders day
Children 11-14 years Both 2700 mg/ NA NA NA ND
genders day
Children 15-17 years Both 3500 mg/ NA NA NA ND
genders day
Adults ≥ 18 years Both 3500 mg/ NA NA NA ND
genders day
Pregnant women ≥ 18 years Female 3500 mg/ NA NA NA ND
day
Lactating women ≥ 18 years Female 4000 mg/ NA NA NA ND
day

Selenium AI: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2014.3846

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both 15 μg/day NA NA NA ND

genders
Children 1-3 years Both 15 μg/day NA NA NA 60 μg/day
genders
Children 4-6 years Both 20 μg/day NA NA NA 90 μg/day
genders
Children 7-10 years Both 35 μg/day NA NA NA 130 μg/day
genders
Children 11-14 years Both 55 μg/day NA NA NA 200 μg/day
genders
Children 15-17 years Both 70 μg/day NA NA NA 250 μg/day
genders
Adults ≥ 18 years Both 70 μg/day NA NA NA 300 μg/day
genders
Pregnant women ≥ 18 years Female 70 μg/day NA NA NA 300 μg/day
Lactating women ≥ 18 years Female 85 μg/day NA NA NA 300 μg/day

Sodium AI: NOT AVAILABLE YET

Safe and adequate intake: https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2019.5778

Age Gender AI AR PRIs RI UL Safe and

adequate
intake

Infants 7-11 months Both 0.2 g/day NA NA NA NA NA

genders
Children 1-3 years Both NA NA NA NA NA 1.1 g/day
genders
Children 4-6 years Both NA NA NA NA NA 1.3 g/day
genders
Children 7-10 years Both NA NA NA NA NA 1.7 g/day
genders
Children 11-17 years Both NA NA NA NA NA 2 g/day
genders

Copyright @2019 EFSA 5/6

 Age Gender AI AR PRIs RI UL Safe and
adequate
intake

Adults ≥ 18 years Both NA NA NA NA NA 2 g/day

genders
Pregnant women ≥ 18 years Both NA NA NA NA NA 2 g/day
genders
Lactating women ≥ 18 years Both NA NA NA NA NA 2 g/day
genders

Zinc AR, PRIs: https://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2014.3844

UL: http://www.efsa.europa.eu/sites/default/files/assets/ndatolerableuil.pdf

Age Gender AI AR PRIs RI UL

Infants 7-11 months Both NA 2.4 mg/day 2.9 mg/day NA ND

genders
Children 1-3 years Both NA 3.6 mg/day 4.3 mg/day NA 7 mg/day
genders
Children 4-6 years Both NA 4.6 mg/day 5.5 mg/day NA 10 mg/day
genders
Children 7-10 years Both NA 6.2 mg/day 7.4 mg/day NA 13 mg/day
genders
Children 11-14 years Both NA 8.9 mg/day 10.7 mg/day NA 18 mg/day
genders
Children 15-17 years Male NA 11.8 mg/day 14.2 mg/day NA 22 mg/day
Children 15-17 years Female NA 9.9 mg/day 11.9 mg/day NA 22 mg/day
Adults (LPI 300 mg/ ≥ 18 years Male NA 7.5 mg/day 9.4 mg/day NA 25 mg/day
day)
Adults (LPI 600 mg/ ≥ 18 years Male NA 9.3 mg/day 11.7 mg/day NA 25 mg/day
day)
Adults (LPI 900 mg/ ≥ 18 years Male NA 11 mg/day 14 mg/day NA 25 mg/day
day)
Adults (LPI 1200 mg/ ≥ 18 years Male NA 12.7 mg/day 16.3 mg/day NA 25 mg/day
day)
Adults (LPI 300 mg/ ≥ 18 years Female NA 6.2 mg/day 7.5 mg/day NA 25 mg/day
day)
Adults (LPI 600 mg/ ≥ 18 years Female NA 7.6 mg/day 9.3 mg/day NA 25 mg/day
day)
Adults (LPI 900 mg/ ≥ 18 years Female NA 8.9 mg/day 11 mg/day NA 25 mg/day
day)
Adults (LPI 1200 mg/ ≥ 18 years Female NA 10.2 mg/day 12.7 mg/day NA 25 mg/day
day)
Pregnant women ≥ 18 years Female NA (+) 1.3 mg/ (+) 1.6 mg/ NA 25 mg/day
day day
Lactating women ≥ 18 years Female NA (+) 2.4 mg/ (+) 2.9 mg/ NA 25 mg/day
day day

For infants and children, the fractional absorption of zinc considered in setting PRIs was based on data from mixed diets expected to contain variable quantities
of phytate; therefore, no adjustment for phytate intake has been made.

For adults, ARs and PRIs for zinc are provided for four levels of phytate intake (LPI): 300, 600, 900 and 1,200 mg/day.

For pregnant and lactating women, the value should be added to the AR/PRI of non-pregnant, non-lactating women.

Copyright @2019 EFSA 6/6